mesoestetic inspire at medical-aesthetics conference
Thousands of dermatologists, plastic surgeons and aesthetic medicine professionals recently gathered in Paris for the IMCAS World Congress 2019.
Now in its 21st year, the event provides an ideal platform for industry companies to present their new products and latest developments to international delegates.
Multinational pharmaceutical company, mesoestetic Pharma Group were one such brand delighted to take part in this year's congress. They presented their new solutions to hyperpigmentation with tranexamic acid, as well as launching their latest home treatment innovation, ha densimatrix, a concentrate based on hyaluronic acid with different molecular forms that provides the skin with a moisturising, antiaging, repulping and filling action.
Congress attendees also had the opportunity to enjoy three days full of high-quality learning and over 700 expert speakers. mesoestetic Pharma Group had an outstanding presence in the congress speeches, two renowned international physicians presented the most recent advances and studies performed with the company solutions. Doctors Adrián Gaspar and Sabine Zenker shared the most recent results of their studies applying mesoestetic laboratory solutions.